PGR and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC), one of five molecular subtypes recognized in 2000 [1,2], lacks estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) expression.